Cargando…

Potential risk of liver injury in epileptic patients during COVID-19 pandemic

Most of the antiseizure medications (ASMs) are metabolized in liver and many of them particularly first-generation ASMs have the potential to increase liver enzymes or induce liver injury. Hence, treatment of new onset seizures or epilepsy by ASMs during the course of coronavirus disease 2019 (COVID...

Descripción completa

Detalles Bibliográficos
Autores principales: Tabrizi, Nasim, Sharifi-Razavi, Athena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9724200/
https://www.ncbi.nlm.nih.gov/pubmed/36483103
http://dx.doi.org/10.5501/wjv.v11.i6.467